NASDAQ: GILD
Gilead Sciences, Inc.
Healthcare · Drug Manufacturers - General
Pre-market: $135.79(-0.06%) · as of 4:05 AM ET
Market Cap
$168.69B
52w High
$157.29
52w Low
$108.46
P/E
20.04
Volume
5.50M
Outstanding Shares
1.24B
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock rose 13.21% over the last year. Revenue grew 5.52% over the trailing twelve months. Operating margin moved from 27.89% to -4.9%. Free cash flow grew 40.88% over the trailing twelve months.
What the market seems to be pricing
The stock is trading toward the richer end of its historical P/FCF range (83rd percentile) while business metrics are improving. More of the upside is already embedded in the multiple now.
What would invalidate this read
Operating margin is at -4.9% — continued expansion would be needed to justify the premium. Revenue growth of 5.52% is encouraging, but any deceleration puts the stretched multiple at risk. This read changes if revenue, margins, and cash flow continue to improve faster than expected — in that case the richer multiple could still prove conservative.
Company profile
Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets.
Valuation
Stock splits
Every 1 shares became 2
Every 1 shares became 2
Every 1 shares became 2
Every 1 shares became 2
Every 1 shares became 2
Profitability & growth
Analyst consensus
39
Buy
18
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Oct 29, 2026
Q4 FY26 · EPS est $2.14 · Revenue est $7.78B
View
Dividends
$3.25/shareQuarterlyDividend Achiever · 10yrSafeGILD pays a dividend with a 2.39% declared yield, 10 consecutive years of growth, growing at 2.95% annually, covered 2.4× by free cash flow.
Declared Yield
2.39%
Annual Div / Share
$3.25
5yr CAGR
+2.95%
Doubles every ~23.8yr
Payout Ratio
47.04%
Safe
Dividend Growth Rate
3yr CAGR
+2.93%
5yr CAGR
+2.95%
10yr CAGR
+6.09%
Dividend History
Annualized dividend cycles per share
Income Projection
Today
$2/mo
In 5 yrs
$2/mo
In 10 yrs
$3/mo
| Today | In 5 yrs | In 10 yrs |
|---|---|---|
$24/yr $2/mo | $28/yr+16% $2/mo | $32/yr+34% $3/mo |
Yield-on-cost grows from 2.39% → 3.2% over 10yr
Analysis
Dividend Strengths
Dividend Achiever
GILD has raised its dividend for 10 consecutive years — qualifying as a Dividend Achiever, demonstrating long-term commitment to shareholder income.
Well-covered by free cash flow
The dividend is covered 2.4× by free cash flow, indicating the company generates sufficient cash to sustain and potentially grow the payout without straining its finances.
Risks to Watch
No strong risk signal stands out from the latest period pair.